ReviewCancer immunology, immunotherapy : CII2016

NK-92: an 'off-the-shelf therapeutic' for adoptive natural killer cell-based cancer immunotherapy.

Garnet Suck et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.